All lots of JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets recalled due to possible incorrect dose, which may pose health risks
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product safety - Dosage
What you should do
- If you are taking the affected products, speak with your pharmacist as soon as possible. It may not be possible to know if you are getting the correct dose of clopidogrel by looking at the tablets since overweight or underweight tablets may look like normal-sized tablets.
- Continue taking your JAMP-Clopidogrel 75 mg or AG-Clopidogrel 75 mg tablets until you speak with your pharmacist and get a replacement product.
- Contact a health care professional immediately if you or someone you are caring for experiences serious side effects related to an incorrect dose of clopidogrel.
- If you have questions about this recall, contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, or Angita Pharma Inc. at 450-449-9272 or by email at custangita@angitapharma.ca.
- Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.